CHICAGO HIGHLIGHTS 2024 – MELANOMA ROUNDTABLE DISCUSSION: Promising updates in uveal melanoma

CHICAGO HIGHLIGHTS 2024 – MELANOMA ROUNDTABLE DISCUSSION: Promising updates in uveal melanoma

Chicago Highlights 2024 Roundtable Discussions
Icon Chair Speaker

Chair

Dr. Vanessa Bernstein

Icon Chair Speaker

Panelists

Prof. Caroline Robert
Dr. Marcus Butler

Studies/trials discussed:

  • Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma (NADOM)
Tagged